NCT07120815View on ClinicalTrials.gov

Optimizing Metformin Use in Polycystic Ovary Syndrome

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Polycystic Ovary Syndrome (PCOS)
Interventions
DRUG

Metformin 1500 mg daily

metformin 500mg tablets, 3 times per day

DRUG

Metformin 2250 mg daily

Metformin 750mg, 3 times daily

Trial Locations (1)

Unknown

The Reproductive Medicine Unit, Helsinki University Hospital, Helsinki

All Listed Sponsors
collaborator

Valtion tutkimusraha (funding)

UNKNOWN

collaborator

Sakari Alhopuro foundation (funding)

UNKNOWN

collaborator

The Medical Society of Finland (funding)

UNKNOWN

lead

Helsinki University Central Hospital

OTHER